Clinical application of microRNAs in glomerular diseases

被引：7
作者：
Selvaskandan, Haresh [1 ]
Pawluczyk, Izabella [1 ]
Barratt, Jonathan [1 ]
机构：
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷 / 06期
关键词：
biomarkers; glomerulonephritis; microRNA; miRNA; therapeutics; IGA NEPHROPATHY; LUPUS NEPHRITIS; EXPRESSION; INFLAMMATION; INJURY; PROGRESSION; BIOGENESIS; MIR-148B; MIR-21; KDM4C;
D O I：
10.1093/ndt/gfac230
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
RNA interference (RNAi) occurs in all organisms and modulates most, if not all, biological pathways. It is the process by which non-coding RNAs, including microRNAs (miRNAs), regulate gene transcription and post-transcriptional processing of messenger RNA (mRNA). A single miRNA can modulate several genes within a cell, and several miRNAs can regulate expression of the same gene, adding tiers of complexity to the regulation of gene expression. miRNAs and other RNAi approaches have been successfully used in vitro and in vivo to selectively manipulate gene transcription, making them pivotal agents for basic science research and candidates for targeted therapeutics. This review focuses on miRNAs and their potential as biomarkers and novel therapeutics for glomerular disease.
引用
收藏
页码：1375 / 1384
页数：10
相关论文
共 77 条
  • [1] Relationship of cell-free urine MicroRNA with lupus nephritis in children
    Abulaban, Khalid M.
    Fall, Ndate
    Nunna, Ravi
    Ying, Jun
    Devarajan, Prasad
    Grom, Alexi
    Bennett, Michael
    Ardoin, Stacy P.
    Brunner, Hermine I.
    [J]. PEDIATRIC RHEUMATOLOGY, 2016, 14
  • [2] Evaluating a New International Risk-Prediction Tool in IgA Nephropathy
    Barbour, Sean J.
    Coppo, Rosanna
    Zhang, Hong
    Liu, Zhi-Hong
    Suzuki, Yusuke
    Matsuzaki, Keiichi
    Katafuchi, Ritsuko
    Er, Lee
    Espino-Hernandez, Gabriela
    Kim, S. Joseph
    Reich, Heather N.
    Feehally, John
    Cattran, Daniel C.
    Russo, M. L.
    Troyanov, S.
    Cook, H. T.
    Roberts, I.
    Tesar, V.
    Maixnerova, D.
    Lundberg, S.
    Gesualdo, L.
    Emma, F.
    Fuiano, L.
    Beltrame, G.
    Rollino, C.
    Amore, A.
    Camilla, R.
    Peruzzi, L.
    Praga, M.
    Feriozzi, S.
    Polci, R.
    Segoloni, G.
    Colla, L.
    Pani, A.
    Piras, D.
    Angioi, A.
    Cancarini, G.
    Ravera, S.
    Durlik, M.
    Moggia, E.
    Ballarin, J.
    Di Giulio, S.
    Pugliese, F.
    Serriello, I.
    Caliskan, Y.
    Sever, M.
    Kilicaslan, I.
    Locatelli, F.
    Del Vecchio, L.
    Wetzels, J. F. M.
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (07) : 942 - 952
  • [3] MicroRNA-126 and micro-/macrovascular complications of type 1 diabetes in the EURODIAB Prospective Complications Study
    Barutta, Federica
    Bruno, Graziella
    Matullo, Giuseppe
    Chaturvedi, Nish
    Grimaldi, Serena
    Schalkwijk, Casper
    Stehouwer, Coen D.
    Fuller, John H.
    Gruden, Gabriella
    [J]. ACTA DIABETOLOGICA, 2017, 54 (02) : 133 - 139
  • [4] microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles
    Bhatt, Kirti
    Mi, Qing-Sheng
    Dong, Zheng
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2011, 300 (03) : F602 - F610
  • [5] Identification, Confirmation, and Replication of Novel Urinary MicroRNA Biomarkers in Lupus Nephritis and Diabetic Nephropathy
    Cardenas-Gonzalez, Mariana
    Srivastava, Anand
    Pavkovic, Mira
    Bijol, Vanesa
    Rennke, Helmut G.
    Stillman, Isaac E.
    Zhang, Xiaolan
    Parikh, Samir
    Rovin, Brad H.
    Afkarian, Maryam
    de Boer, Ian H.
    Himmelfarb, Jonathan
    Waikar, Sushrut S.
    Vaidya, Vishal S.
    [J]. CLINICAL CHEMISTRY, 2017, 63 (09) : 1515 - 1526
  • [6] MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
    Chen, Hai-Yong
    Zhong, Xiang
    Huang, Xiao R.
    Meng, Xiao-Ming
    You, Yongke
    Chung, Arthur C. K.
    Lan, Hui Y.
    [J]. MOLECULAR THERAPY, 2014, 22 (04) : 842 - 853
  • [7] Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
    Corbett, Kizzmekia S.
    Flynn, Barbara
    Foulds, Kathryn E.
    Francica, Joseph R.
    Boyoglu-Barnum, Seyhan
    Werner, Anne P.
    Flach, Britta
    O'Connell, Sarah
    Bock, Kevin W.
    Minai, Mahnaz
    Nagata, Bianca M.
    Andersen, Hanne
    Martinez, David R.
    Noe, Amy T.
    Douek, Naomi
    Donaldson, Mitzi M.
    Nji, Nadesh N.
    Alvarado, Gabriela S.
    Edwards, Darin K.
    Flebbe, Dillon R.
    Lamb, Evan
    Doria-Rose, Nicole A.
    Lin, Bob C.
    Louder, Mark K.
    O'Dell, Sijy
    Schmidt, Stephen D.
    Phung, Emily
    Chang, Lauren A.
    Yap, Christina
    Todd, John-Paul M.
    Pessaint, Laurent
    Van Ry, Alex
    Browne, Shanai
    Greenhouse, Jack
    Putman-Taylor, Tammy
    Strasbaugh, Amanda
    Campbell, Tracey-Ann
    Cook, Anthony
    Dodson, Alan
    Steingrebe, Katelyn
    Shi, Wei
    Zhang, Yi
    Abiona, Olubukola M.
    Wang, Lingshu
    Pegu, Amarendra
    Yang, Eun Sung
    Leung, Kwanyee
    Zhou, Tongqing
    Teng, I-Ting
    Widge, Alicia
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (16) : 1544 - 1555
  • [8] The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis
    Costa-Reis, Patricia
    Russo, Pierre A.
    Zhang, Zhe
    Colonna, Lucrezia
    Maurer, Kelly
    Gallucci, Stefania
    Schulz, Steffan W.
    Kiani, Adnan N.
    Petri, Michelle
    Sullivan, Kathleen E.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67 (09) : 2415 - 2426
  • [9] MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
    Ebert, Margaret S.
    Neilson, Joel R.
    Sharp, Phillip A.
    [J]. NATURE METHODS, 2007, 4 (09) : 721 - 726
  • [10] Association of microRNA-125a with the clinical features, disease activity and inflammatory cytokines of juvenile-onset lupus patients
    Eissa, Eman
    Morcos, Botros
    Abdelkawy, Rania Fawzy Mahmoud
    Ahmed, Hanan H.
    Kholoussi, Naglaa M.
    [J]. LUPUS, 2021, 30 (07) : 1180 - 1187
12345678